Spontaneous Reporting Method Used for Safety Evaluation of Nonsteroidal Anti-Inflammatory Drugs and Paracetamol Products, Based on Assessment of Data from Periodic Reports

QR Code

Spontaneous Reporting Method Used for Safety Evaluation of Nonsteroidal Anti-Inflammatory Drugs and Paracetamol Products, Based on Assessment of Data from Periodic Reports

High rates of adverse drug reactions (ADRs) associated with nonsteroidal anti-inflammatory drugs (NSAIDs), as well as their irrational and uncontrolled use for self-medication require continuous updating of information on safety profiles of these products.The aim of the study was to assess the repor...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. V. Matveev, E. A. Egorova, A. E. Krasheninnikov, E. I. Konyaeva
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-04-01
Series:	Безопасность и риск фармакотерапии
Subjects:	adverse drug reactions nonsteroidal anti-inflammatory drugs spontaneous reports patient-related units of time pharmacovigilance safety diclofenac acetylsalycilic acid paracetamol
Online Access:	https://www.risksafety.ru/jour/article/view/266
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adverse Effects of Nonsteroidal Anti-inflammatory Drugs in Pediatrics: Case Series According to the Doctor Reports in Republic of Crimea through 2010 to 2018
by: Alexandr V. Matveev, et al.
Published: (2019-09-01)

Retrospective Analysis of Spontaneous Reports of Fatal Adverse Reactions Associated with Lidocaine
by: A. V. Matveev, et al.
Published: (2024-04-01)

Levofloxacin: Analysis of Information on Adverse Reactions from Russian Spontaneous Report Database
by: S. K. Zyryanov, et al.
Published: (2020-05-01)

IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
by: Yu. V. Muravyev
Published: (2017-09-01)

ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS
by: O. V. Shatalova, et al.
Published: (2015-09-01)

Modern approaches to collecting and reporting information on side effects
by: K. E. Zatolochina, et al.
Published: (2018-02-01)

Medication Errors Associated with the Use of Levofloxacin: An Analysis of the National Database of Spontaneous Reports
by: I. L. Asetskaya, et al.
Published: (2025-04-01)

Rational Organisation of Adverse Drug Reaction Monitoring
by: L. V. Shukil, et al.
Published: (2022-10-01)

Off-Label Prescribing in Paediatric Cardiology: Regulatory Aspects and Safety Assessment by Spontaneous Reporting
by: E. O. Kochkina, et al.
Published: (2023-03-01)

Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia
by: E. N. Tkhoseva, et al.
Published: (2022-06-01)

Review of publications on drug-related problems investigations in osteoporosis patients
by: E. A. Egorova, et al.
Published: (2024-01-01)

Morphofunctional changes and mechanisms of their realization in developing lungs under influence of paracetamol and nimesulid
by: Kharchenko S.V., et al.
Published: (2012-01-01)

Spontaneous Adverse Drug Reaction Reporting of Congenital Malformations: A Danish National Register Study
by: Ulrik Lausten-Thomsen, et al.
Published: (2025-06-01)

Adverse Reactions of Drugs Containing Valeriana and Corvalol: Analysis of Spontaneous Reporting
by: S. L. Morokhina, et al.
Published: (2018-12-01)

Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment
by: E. Yu. Demchenkova, et al.
Published: (2021-03-01)

Ultra violet spectrophotometric analysis of Paracetamol, Diclofenac and Tramadol drugs in mixture
by: Eesa M. Thalij, et al.
Published: (2019-05-01)

Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them
by: N. V. Pyrikova, et al.
Published: (2019-11-01)

Adverse events associated with gepants: a pharmacovigilance analysis based on the FDA adverse event reporting system
by: Qi Song, et al.
Published: (2025-06-01)

Analysis of Data on Adverse Drug Reactions and Functional Flaws of the Pharmacovigilance System Associated with Self-Treatment with Antibiotics
by: N. V. Verlan, et al.
Published: (2022-10-01)

INVESTIGATION OF MEDICALLY INDUCED SKIN REACTIONS BASED ON THE ANALYSIS OF REPORTS OF ADVERSE DRUG REACTIONS IN THE REPUBLIC OF CRIMEA (FROM 2009 TO 2016)
by: A. V. Matveev, et al.
Published: (2019-03-01)

Improving the Pharmacovigilance System in Medical Organisations as an Opportunity to Enhance the Quality of Pharmacotherapy
by: M. V. Zhuravleva, et al.
Published: (2025-04-01)

Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025
by: V. I. Petrov
Published: (2025-01-01)

Exploring Ototoxicity Associated with Capmatinib: Insights from a Real-World Data Analysis of the FDA Adverse Event Reporting System (FAERS) Database
by: Lin Y, et al.
Published: (2025-06-01)

Role of Pharmacovigilance in Drug Safety Monitoring
by: Anju E. Paul, et al.
Published: (2025-07-01)

APPLICATION OF DRUG-RELATED PROBLEMS APPROACH TO ANALYSIS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS’ SAFETY
by: A. V. Matveev, et al.
Published: (2019-09-01)

Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin
by: N. V. Molchan, et al.
Published: (2019-06-01)

The problem in the evaluation of the efficacy and safety of nonsteroidal anti-inflammatory drugs
by: N. V. Chichasova
Published: (2016-06-01)

GENDER CHARACTERISTICS OF ADVERSE DRUG REACTIONS DEVELOPMENT: EXPERIENCE OF REGIONAL DATABASE ANALYSIS
by: A. V. Matveev, et al.
Published: (2022-05-01)

COMPARATIVE REVIEW OF METHODOLOGIES FOR ESTIMATING THE COST OF ADVERSE DRUG REACTIONS IN THE RUSSIAN FEDERATION AND BRAZIL
by: G. I. Syraeva, et al.
Published: (2021-03-01)

Quantitative Signal Detection for COVID-19 Medicinal Products Based on Retrospective Analysis of Spontaneous Reports from the Russian Pharmacovigilance Database
by: S. A. Mishinova, et al.
Published: (2024-04-01)

An e‐Reporting Tool for Facilitating Submission of Veterinary Adverse Drug Reaction Reports
by: Heather Davies, et al.
Published: (2025-07-01)

Assessment of pharmacovigilance knowledge and ADR reporting skills in undergraduate medical students using the OSPA model
by: T.Y. Sree Sudha, et al.
Published: (2025-12-01)

Aspects of the Safe Use of Antibacterial Drugs in Community-Acquired Pneumonia: the Implications of Drug-Drug Interactions
by: A. A. Taube, et al.
Published: (2022-08-01)

ANALYSIS OF ADVERSE DRUG REACTION REPORT FORMS ON THE MEDICINES, USED FOR AIDS TREATMENT (REGISTERED IN THE REPUBLIC OF CRIMEA IN THE PERIOD FROM 2011 TO 2016)
by: A. V. Matveev, et al.
Published: (2019-01-01)

Analysis of pharmacy organisation staff awareness of pharmacovigilance
by: R. I. Yagudina, et al.
Published: (2025-06-01)

Safety of Lipid-Lowering Therapy with Statins according to a Regional Pharmacovigilance Centre
by: E. O. Kochkina, et al.
Published: (2023-09-01)

International Drug Safety Monitoring
by: A. S. Kazakov, et al.
Published: (2019-09-01)

STABILITY OF DRUG FORM OF PARACETAMOL, FORMED ON THE BASIS OF CRYSTALS OF ROMBIC MODIFICATION
by: A. P. Belyaev, et al.
Published: (2019-01-01)

EFFICIENCY OF METHOD OF SPONTANEOUS NOTIFICATION ABOUT UNDESIRABLE DRUG REACTIONS IN VOLGOGRAD
by: O. N. Smuseva, et al.
Published: (2015-09-01)

DEBATABLE PROBLEMS OF PHARMACOVIGILANCE
by: Yu. V. Muravyev, et al.
Published: (2018-03-01)